U.S. Markets close in 2 hrs.

Repros Therapeutics Inc. (RPRX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.3003-0.0097 (-3.1290%)
As of 1:58PM EDT. Market open.
People also watch
SNSSOPXATHLDCYCCOGXI
Full screen
Previous Close0.3100
Open0.3120
Bid0.3001 x 400
Ask0.3049 x 100
Day's Range0.2980 - 0.3240
52 Week Range0.2600 - 2.2800
Volume125,586
Avg. Volume404,796
Market Cap11.3M
Beta-0.29
PE Ratio (TTM)-0.48
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Associated Presslast month

    Repros Therapeutics reports 2Q loss

    The The Woodlands, Texas-based company said it had a loss of 8 cents per share. The biopharmaceutical company posted revenue of $7,000 in the period. The company's shares closed at 35 cents. A year ago, ...

  • Repros (RPRX) Q2 Earnings: What's in Store for the Stock?
    Zacks2 months ago

    Repros (RPRX) Q2 Earnings: What's in Store for the Stock?

    Lack of revenues in Repros Therapeutics' (RPRX) product portfolio could be a concern. But the company's most advanced pipeline candidates -- enclomiphene and Proellex -- might better its results in Q2.

  • Repros' Proellex Stays on Partial Clinical Hold, Shares Fall
    Zacks2 months ago

    Repros' Proellex Stays on Partial Clinical Hold, Shares Fall

    Repros Therapeutics Inc. (RPRX) announced that its pipeline candidate Proellex which is being evaluated for uterine fibroids will remain on partial clinical hold.